NBTX

26.5002.98%
LA

Leonard A. Farber

Chief Clinical and Medical Affairs Officer & Chairman of the Scientific Advisory Board

Dr. Leonard A. Farber, M.D., is Chief Clinical & Medical Affairs Officer of Nanobiotix S.A. from February 2022 and serves as its Chairman of the Scientific Advisory Board. Dr. Farber is Section Chief of Radiation Oncology and Senior Medical Director of Care To Care, LLC. Dr. Farber is Principal of Healthcare & Life Sciences of Vivaris Capital, LLC from 2022. Dr. Farber was Member of Scientific Advisory Board of Adgero Biopharmaceuticals Holdings, Inc. Dr. Farber joined the Adgero Biopharmaceuticals Holdings, Inc. on April 14, 2016. Dr. Farber was Member of Scientific Advisory Board of Adgero Biopharmaceuticals Holdings, Inc. Dr. Farber has B.A. from State University of New York at Binghamton, B.S. from State University of New York at Binghamton, M.D. from Icahn School of Medicine at Mount Sinai.

Positions